2021
DOI: 10.21203/rs.3.rs-64052/v3
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Clinical utility of procalcitonin in febrile infants younger than 3 months of age visiting a pediatric emergency room: A retrospective single-center study

Abstract: BackgroundFever in infants under 90 days of age is highly likely to be caused by a severe bacterial infection (SBI) and it accounts for a large number of patients visiting the pediatric emergency room. In order to predict the bacterial infection and reduce unnecessary treatment, the classic classification system is based on white blood cell (WBC) count, urinalysis, and x-ray, and it is modified and applied at each center by incorporating recently studied biomarkers such as c-reactive protein (CRP) or procalcit… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…Young febrile infants (defined as 90 days of age or younger with a history of fever) are at a relatively high risk of invasive bacterial infections (IBIs) compared with older children 1–3. Invasive bacterial infections include bacterial meningitis and symptomatic bacteraemia and are reported in 1%–3% of young febrile infants 1–5. In addition to IBI, a further 10%–15% of young febrile infants will be diagnosed with other serious bacterial infections (SBIs); typically urinary tract infections (UTIs) requiring antibiotic treatment 1 3 6.…”
Section: Introductionmentioning
confidence: 99%
“…Young febrile infants (defined as 90 days of age or younger with a history of fever) are at a relatively high risk of invasive bacterial infections (IBIs) compared with older children 1–3. Invasive bacterial infections include bacterial meningitis and symptomatic bacteraemia and are reported in 1%–3% of young febrile infants 1–5. In addition to IBI, a further 10%–15% of young febrile infants will be diagnosed with other serious bacterial infections (SBIs); typically urinary tract infections (UTIs) requiring antibiotic treatment 1 3 6.…”
Section: Introductionmentioning
confidence: 99%